Details of issuance or disposal
13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
Number of shares issued upon exercise since the previous disclosure: 143,000 shares
0.27% (exercise ratio subject to the exercise limit; the ratio of shares issued upon exercise this time to total issued shares is not stated)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | 13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Number of shares issued upon exercise since the previous disclosure: 143,000 shares |
| Dilution Rate | 0.27% (exercise ratio subject to the exercise limit; the ratio of shares issued upon exercise this time to total issued shares is not stated) |
| Total number of issued shares | 59,135,100 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | ¥70 (each exercise date in September 2026). Details of the adjustment provision and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed. Unexercised balance at the time of the previous disclosure: 15,059 units; current unexercised balance: 13,629 units |
| Procedures under the Corporate Code of Conduct | Describes compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, etc. |
| Most recent equity financing | Timing 13 January 2026 / Type 13th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 13th Series Stock Acquisition Rights in September 2026.